Biomarkers of endothelial dysfunction in patients with nonalcoholic fatty liver disease (NAFLD)

被引：0

作者：

Montero-Vallejo, Rocio ^{[1
,2
,3
]}

Gallego-Duran, Rocio ^{[1
,2
,3
]}

Maya, Douglas ^{[1
,2
,3
]}

Gato Zambrano, Sheila ^{[1
,2
,3
]}

Garcia Fernandez, Vanessa ^{[1
,2
,3
]}

Munoz Hernandez, Rocio ^{[1
,2
,3
]}

Gil-Gomez, Antonio ^{[1
,2
,3
]}

Alvarez-Ossorio, Angela Rojas ^{[1
,2
,3
]}

Fernandez-Barrena, Maite G. ^{[4
]}

Maria Herranz, Jose ^{[4
]}

Hernandez-Gea, Virginia ^{[5
]}

Camprecios, Genis ^{[5
]}

Anton, Aina ^{[5
]}

del Carmen Rico, Maria ^{[1
,2
,3
]}

Martin-Bermudo, Franz ^{[6
]}

Romero Gomez, Manuel ^{[1
,2
,3
]}

Ampuero, Javier ^{[1
,2
,3
]}

机构：

[1] Hosp Univ Virgen Rocio, Serv Aparato Digest, Seville, Spain

[2] Univ Seville, Inst Biomed Sevilla HUVR CSIC US, SeLiver Grp, Seville, Spain

[3] CIBEREHD Sevilla, Seville, Spain

[4] Univ Navarra, Programa Hepatol, CIMA, CIBEREHD, Pamplona, Spain

[5] Univ Barcelona, Hosp Clin, Unidad Hemodinam Hepat, IDIBAPS,Serv Hepatol,CIBEREHD, Barcelona, Spain

[6] Ctr Andaluz Biol Mol Med Regenerat CABIMER, Seville, Spain

来源：

JOURNAL OF HEPATOLOGY | 2023年 / 78卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

WED-457

引用

页码：S770 / S772

页数：3

共 50 条

[41] Assessment of endothelial function in patients with nonalcoholic fatty liver disease
Colak, Yasar
Senates, Ebubekir
Yesil, Atakan
Yilmaz, Yusuf
Ozturk, Oguzhan
Doganay, Levent
Coskunpinar, Ender
Kahraman, Ozlem Timirci
Mesci, Banu
Ulasoglu, Celal
Tuncer, Ilyas
ENDOCRINE, 2013, 43 (01) : 100 - 107
[42] Assessment of endothelial function in patients with nonalcoholic fatty liver disease
Yasar Colak
Ebubekir Senates
Atakan Yesil
Yusuf Yilmaz
Oguzhan Ozturk
Levent Doganay
Ender Coskunpinar
Ozlem Timirci Kahraman
Banu Mesci
Celal Ulasoglu
Ilyas Tuncer
Endocrine, 2013, 43 : 100 - 107
[43] BREAKING DOWN BARRIERS TO EXERCISE IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Soriano, Christopher
Rivas, Gloriany
Hummer, Breianna L.
Yoo, Esther Y.
Schmitz, Kathryn
Sciamanna, Christopher
Stine, Jonathan G.
GASTROENTEROLOGY, 2020, 158 (06) : S1446 - S1446
[44] ROLE OF PHARMACOTHERAPY IN REAL WORLD PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Eghbali, Shabnam
Newberry, Carolyn
Yeung, Michele
Sharaiha, Reem Z.
Kumar, Sonal
GASTROENTEROLOGY, 2021, 160 (06) : S839 - S839
[45] PREVALENCE OF NONALCOHOLIC FATTY LIVER DISEASE (NAFLD) AND METABOLIC SYNDROME IN PATIENTS WITH PSORIASIS
Miele, L.
De Simone, C.
Cefalo, C.
Vallone, S.
Bussoletti, C.
Forgione, A.
Gabrieli, M. L.
Vero, V.
Di Stasi, C.
D'Agostino, M.
Amerio, P.
Gasbarrini, G.
Grieco, A.
DIGESTIVE AND LIVER DISEASE, 2008, 40 : S179 - S179
[46] The Potential Role of Serum Endocan in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
Elsheikh, Elzafir
Younoszai, Zahra
Hunt, Sharon L.
Otgonsuren, Munkhzul
Raybuck, Bryan
Younossi, Zobair M.
GASTROENTEROLOGY, 2013, 144 (05) : S1022 - S1022
[47] Noninvasive assessment of fibrosis among patients with nonalcoholic fatty liver disease [NAFLD]
Bernstein, David
Kovalic, Alexander J.
METABOLISM OPEN, 2022, 13
[48] Outcomes of Concomitant Opiate Use in Patients With Nonalcoholic Fatty Liver Disease (NAFLD)
Dasu, Neethi
Khalid, Yaser
Dasu, Kirti
Khalid, Fizan
Joo, Lucy
AMERICAN JOURNAL OF GASTROENTEROLOGY, 2022, 117 (10): : S999 - S999
[49] CHARACTERISTICS OF THE FATTY ACID COMPOSITION IN NONALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Yamada, K.
Mizukoshi, E.
Takeshita, Y.
Arai, K.
Yamashita, T.
Sakai, A.
Kaneko, S.
JOURNAL OF HEPATOLOGY, 2011, 54 : S505 - S506
[50] Berberine ameliorates intestinal mucosal barrier dysfunction in nonalcoholic fatty liver disease (NAFLD) rats
Wang, Yuzhen
Cui, Suxian
Zheng, Jimin
Li, Yueqin
Li, Pingping
Hou, Hongtao
JOURNAL OF KING SAUD UNIVERSITY SCIENCE, 2020, 32 (05) : 2534 - 2539

← 1 2 3 4 5 →